Breaking Biotech

001 - ADMS drops on Osmolex ER judgement!


Listen Later

-ADMS stock price takes a hit after FDA approval of Osmolex ER and Delaware judicial decision. -I still believe the company has major upside. http://files.shareholder.com/downloads/AMDA-2MCUO2/6060881861x0x970827/E15BD699-5A1F-4AC9-AEA7-5820EAED669C/ADAMASCorpPresentationFebruary18_v1.0.pdf
...more
View all episodesView all episodes
Download on the App Store

Breaking BiotechBy Matthew Lepoire

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

24 ratings